OSLO, Norway, May 3, 2023 /PRNewswire/ -- Photocure ASA (OSE: PHO), held its annual general meeting on 3 May 2023 at 17:00 hours (CET).

The minutes from the general meeting setting out the resolved resolutions are attached hereto.

For further information, please contact:

Photocure

CFO Erik Dahl

Tel: + 47 450 55 000

Email: ed@photocure.no

About Photocure ASA

Photocure: The Bladder Cancer Company delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com.

This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

The following files are available for download:

https://mb.cision.com/Main/17498/3763249/2031409.pdf	Release
https://mb.cision.com/Public/17498/3763249/ad5d353a218af8b6.pdf	Photocure - Minutes from AGM 2023 ENG
https://mb.cision.com/Public/17498/3763249/b7bb5ae4416dddbb.pdf	Photocure - Minutes from AGM 2023 NOR

View original content:https://www.prnewswire.com/news-releases/photocure-asa--annual-general-meeting-held-301814932.html

SOURCE Photocure

Photocure ASA - Annual general meeting held